Dietary advanced glycation end-products and mortality after breast cancer in the Women's Health Initiative
Cancer Epidemiology, Biomarkers & Prevention Oct 27, 2021
Omofuma OO, Peterson LL, Turner DP, et al. - In postmenopausal women suffering from breast cancer, higher consumption of advanced glycation end-products (AGE) was identified to be related to higher risk of major causes of mortality.
A study of 2,023 postmenopausal women (aged 50 to 79 years) from Women's Health Initiative with first primary invasive breast cancer who completed a food frequency questionnaire post-diagnosis.
Adjusted hazard ratios (HR) were calculated for the link between tertiles of postdiagnosis N ε -carboxymethyl-lysine (CML)-AGE intake and death risk from all causes, breast cancer, and cardiovascular disease.
Post-follow-up (a median 15.1 years), there were 630 deaths due to all causes (193 were breast cancer–related, and 129 were cardiovascular disease–related).
CML-AGE intake after diagnosis was related to all-cause (HR T3vsT1 , 1.37), breast cancer (HR T3vsT1 , 1.49), and cardiovascular disease (HR T3vsT1 , 1.91) mortality.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries